2d
GlobalData on MSNThermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unitGlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...
The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
Key Takeaways Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...
Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...
Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs.
Thermo Fisher Scientific plans to acquire Solventum's Purification and Filtration business for $4.1 billion in cash.
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results